Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma - Scorecard - MDSpire

Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma

  • By

  • Ping Huang

  • Fenping Zhang

  • Yuchun Lin

  • Jie Peng

  • Zesong Yang

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Correction: Investigating the Prognostic Significance of Integrated Evaluation of Bone Marrow Plasma Cell Characteristics, Vitamin D Levels, and Interleukin-6 in Multiple Myeloma

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingFirst Affiliated Hospital of Chongqing Medical University and Fengdu County Traditional Chinese Medicine Hospital (source needed)

Key Highlights

  • Correction of ethics approval number for the study (contextualize with correction details)
  • Informed consent obtained from all participants (contextualize with correction details)

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Include specific treatment insights if available.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Exploring the prognostic value of combined assessment of bone marrow plasma cell morphology, Vitamin D, and interleukin-6 in multiple myeloma

            • by Ping Huang, Fenping Zhang, Yuchun Lin, Jie Peng, Zesong Yang

            • June 10, 2026

            Related Content

            Case Report: A diagnostic chameleon of EBV-associated immune dysregulation: HLH unmasking multiple myeloma with subsequent emergence of aggressive B-cell lymphoma

            Romiplostim N01 Enhances Platelet Recovery in Autologous Stem Cell Transplantation with Non-Cryopreserved Peripheral Blood Stem Cells for Plasma Cell Disorders

            Biology of p53 protein isoforms and their significance in hematological malignancies